Latest Anadis Stories
Anadis, a biopharmaceutical company, has announced that it has been informed by the Australian National Center in HIV Epidemiology and Clinical Research and the University of New South Wales, both in Sydney, that their institutional review board has approved a major, Phase IV multisite randomized double-blind placebo controlled study of the company's new product, BioGard.
Anadis (ASX: ANX; OTC: ANDIY) announced today its commercialization of a new product, BioGard(TM), intended to maintain gastrointestinal and immune system health. The specific formulation may be of particular clinical benefit in persons undergoing antiretroviral therapy for HIV/AIDS.
Anadis Ltd. (ASX:ANX; OTC:ANDIY) an Australian biopharmaceutical company has been awarded a product development grant for its Cancer-related Alimentary Mucositis project.
- A gift; a largess; a gratuity; a present; a dole.